Early findings from a four-country study show measurable reductions in preventable medication harm.
The AMTMTI Research Division has released early findings from its flagship medication safety trial, conducted across four countries. The study demonstrates measurable reductions in preventable medication-related harm where pharmacist-led MTM interventions were implemented.
This work forms part of AMTMTI's broader 2030 strategy to embed medication therapy management across African health systems — training professionals, generating evidence, and building a continent-wide community of practice committed to safer medication use.
